Equity Valuation: Stock Analysis, Methodology & Investment Insights

Professional investors use multiple equity valuation methods in parallel. Discounted cash flow analysis estimates intrinsic value based on projected future cash flows. Comparable company analysis values a stock relative to peer group multiples. Precedent transaction analysis uses M&A deal multiples as benchmarks. Sum-of-parts analysis is used for diversified businesses where different divisions have different value drivers.

A simple equity valuation example involves estimating a company's annual free cash flow, projecting growth over a forecast period, applying a terminal growth rate, and discounting back to present value using a risk-adjusted discount rate. The result is compared to the current market capitalisation to assess whether the stock is overvalued, fairly valued, or undervalued relative to the DCF-implied intrinsic value.

Discounted cash flow analysis values a company by projecting future free cash flows and discounting them back to present value using a rate that reflects the risk of those cash flows. It is most useful when a company has stable, predictable cash flows and when the analyst has reasonable confidence in multi-year projections. DCF is less reliable for early-stage companies, highly cyclical businesses, or companies undergoing significant business model transitions.

Equity valuation methods vary significantly by sector. Banks are typically valued on price-to-book and return on equity. REITs are valued on funds from operations and cap rates. Biotech pre-revenue companies are valued on risk-adjusted NPV of pipeline assets. High-growth technology companies are valued on EV/revenue multiples. Using the wrong valuation methodology for a given sector produces misleading conclusions.